Pure red cell aplasia after hematopoietic stem cell transplantation - experimental therapeutic approaches

Click to increase image sizeClick to decrease image size

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was supported by the Helse Vest, Rakel and Otto Kristian Bruuns fund, the Øyvind Mølbach Petersens fund, and the Norwegian Society of Internal Medicine.